본문 바로가기
KERD
논문KCI 등재

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?

2

조회

0

다운로드

7

인용

0

참고문헌

키워드

초록

Background/Aims: Surveillance for hepatocellular carcinoma (HCC) with ultrasound in high-risk populations is generally believed to improve opportunities for treatment. However, tumors are still missed due to various factors. This study explores success versus failure of HCC surveillance. Methods: This is a retrospective study of 1,125 HCC cases. Categories considered for successful detection were largest tumor ≤3.0 cm, single tumors ≤3.0 cm and ≤2.0 cm, and adherence to Milan criteria. Examined factors were age <60 years, gender, rural residence, body-mass index (BMI), hepatitis infection, smoking, diabetes, hyperlipidemia, cirrhosis, ascites, and Model for End-Stage Liver Disease <10. Results: HCC was found on surveillance in 257 patients with a mean tumor size of 3.17 cm; multiple tumors were seen in 28% of cases, bilateral tumors in 7.4%, and vascular invasion in 3.7%. Surveillance was successful in 61.5% of cases involving a largest tumor ≤3.0 cm, with BMI ≥35 negatively affecting detection (odds ratio [OR] 0.28, P=0.014) and cirrhosis positively affecting detection (OR 2.31, P=0.036). Ultrasound detected 19.1% of single tumors ≤2.0 cm with ascites improving the detection rate (OR 3.89, P=0.001). Finally, adherence to Milan criteria occurred in 75.1% of cases, revealing negative associations with diabetes (OR 0.48, P=0.044 and male gender (OR 0.49, P=0.08). Conclusions: Although surveillance is recommended for HCC, not all surveillance ultrasound are ideal. Tumor detection can depend on gender, BMI, diabetes, cirrhosis, and ascites and is achieved in 19.1–75% of cases depending on the definition of success. Closer follow-up or additional imaging might be necessary for some patient subgroups.

Abstract

Background/Aims: Surveillance for hepatocellular carcinoma (HCC) with ultrasound in high-risk populations is generally believed to improve opportunities for treatment. However, tumors are still missed due to various factors. This study explores success versus failure of HCC surveillance. Methods: This is a retrospective study of 1,125 HCC cases. Categories considered for successful detection were largest tumor ≤3.0 cm, single tumors ≤3.0 cm and ≤2.0 cm, and adherence to Milan criteria. Examined factors were age <60 years, gender, rural residence, body-mass index (BMI), hepatitis infection, smoking, diabetes, hyperlipidemia, cirrhosis, ascites, and Model for End-Stage Liver Disease <10. Results: HCC was found on surveillance in 257 patients with a mean tumor size of 3.17 cm; multiple tumors were seen in 28% of cases, bilateral tumors in 7.4%, and vascular invasion in 3.7%. Surveillance was successful in 61.5% of cases involving a largest tumor ≤3.0 cm, with BMI ≥35 negatively affecting detection (odds ratio [OR] 0.28, P=0.014) and cirrhosis positively affecting detection (OR 2.31, P=0.036). Ultrasound detected 19.1% of single tumors ≤2.0 cm with ascites improving the detection rate (OR 3.89, P=0.001). Finally, adherence to Milan criteria occurred in 75.1% of cases, revealing negative associations with diabetes (OR 0.48, P=0.044 and male gender (OR 0.49, P=0.08). Conclusions: Although surveillance is recommended for HCC, not all surveillance ultrasound are ideal. Tumor detection can depend on gender, BMI, diabetes, cirrhosis, and ascites and is achieved in 19.1–75% of cases depending on the definition of success. Closer follow-up or additional imaging might be necessary for some patient subgroups.

참고문헌 (32)

  1. "GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide:IARC CancerBase No. 11. International Agency for Research on Cancer" (2013)[URL]
  2. Ryerson AB, "Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer", Cancer, 122, pp.1312~1337 (2016)
  3. "SEER Cancer Statistics Review, 1975-2013, based on November 2015 SEER data submission"[URL]
  4. Zhang BH, "Randomized controlled trial of screening for hepatocellular carcinoma", J Cancer Res Clin Oncol, 130, pp.417~422 (2004)
  5. Singal AG, "Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis", PLoS Med, 11, pp.e1001624~ (2014)[DOI]
  6. Chalasani N, "Screening for hepatocellular carcinoma in patients with advanced cirrhosis", Am J Gastroenterol, 94, pp.2988~2993 (1999)
  7. Bruix J, "Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
  8. Bruix J, "Management of hepatocellular carcinoma: an update", Hepatology, 53, pp.1020~1022 (2011)
  9. Davila JA, "Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States", Hepatology, 52, pp.132~141 (2010)
  10. Finberg HJ, "Whither (wither?) the ultrasound specialist?", J Ultrasound Med, 23, pp.1543~1547 (2004)
  11. Edge SB, "AJCC cancer staging manual", pp.191~199 (2009), Springer
  12. Wong LL, "Improved survival with screening for hepatocellular carcinoma", Liver Transplant, 6, pp.320~325 (2000)
  13. Chen THH, "Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan", Int J Cancer, 98, pp.257~261 (2002)
  14. Yeh YP, "Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan", Hepatology, 59, pp.1840~1849 (2014)
  15. Trevisani F, "Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)", Am J Gastroenterol, 97, pp.734~744 (2002)
  16. El-Serag HB, "Hepatocellular Carcinoma", N Engl J Med, 365, pp.1118~1127 (2011)
  17. Tanaka H, "Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival", Liver Int, 26, pp.543~551 (2006)
  18. Wong GL, "Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis", Liver Int, 28, pp.79~87 (2007)
  19. Tong MJ, "Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B:results from a community-based clinic", Dig Dis Sci, 55, pp.826~835 (2010)
  20. Singal A, "Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis", Aliment Pharmacol Ther, 30, pp.37~47 (2009)
  21. Del Poggio P, "Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis", Clin Gastroenterol Hepatol, 12, pp.1927~1933 (2014)
  22. Singal AG, "Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?", Am J Gastroenterol, 108, pp.425~432 (2013)
  23. Uppot RN, "Impact of obesity on medical imaging and image-guided intervention", AJR Am J Roentgenol, 188, pp.433~440 (2007)
  24. Yu NC, "CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis", Clin Gastroenterol Hepatol, 9, pp.161~167 (2011)
  25. Rothman KJ, "BMI-related errors in the measurement of obesity", Int J Obes (Lond), 32(Suppl 3), pp.S56~S59 (2008)
  26. Davila JA, "Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study", Gut, 54, pp.533~539 (2005)
  27. Mustard CA, "Sex differences in the use of health care services", N engl J Med, 338, pp.1678~1683 (1998)
  28. Davis JL, "Gender differences in cancer screening beliefs, behaviors and willingness to participate:implications for health promotion", Am J Mens Health, 6, pp.211~217 (2012)
  29. Kim PN, "Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤3cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility", J Vasc Interv Radiol, 23, pp.627~634 (2012)
  30. Rhim H, "Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites", Abdom Imaging, 34, pp.371~380 (2009)
  31. Singal AG, "Failure rates in the hepatocellular carcinoma surveillance process", Cancer Prev Res (Phila), 5, pp.1124~1130 (2012)

관련 논문AI추천

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?Amit G. Singal, Ibrahim A. Hanouneh, Naim Alkhouri대한간학회 · Clinical and Molecular Hepatology2019 · 제25권 제3호Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standardJamak Modaresi Esfeh, Kaveh Hajifathalian, Kianoush Ansari-Gilani대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제1호Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver diseaseAmit G. Singal, Darine Daher, Karim Seif El Dahan대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study김범희, 김진욱, 이정섭, 이주현, 임상혁, 장은선, 정숙향, 정정화대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions김명진, 박미숙, 서니은, 안찬식, 이진영, 한경화, Gulbahor Rakhmonova대한간학회 · Clinical and Molecular Hepatology2017 · 제23권 제1호Alternative Surveillance Improves Outcomes by Detecting Early-Stage Hepatocellular Carcinoma in Chronic Hepatitis B PatientsCho Eun Ju, Cho Heejin, Kim Yoon Jun, Lee Dong Ho, Lee Jeong-Hoon, Lee Yun Bin, Park Min Kyung, Yoon Jung-Hwan, Yu Su Jong거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제5호

이 간행물의 다른 논문 (4건)